|
|
|||||||||
Basic Science Investigations |
1 Centre dExploration et de Recherche Médicales par Émission de Positons, Biomedical Cyclotron, Lyon, France
2 CNRS ERS2019, Villeurbanne, France
3 Institut de Physique Nucléaire, Orsay, France
Our aim was to show the ability of a recently developed ß+-rangesensitive intracerebral probe (SIC) to measure, in vivo, the binding of radioligands in small animals. Methods: The potential of the device for pharmacokinetic studies was evaluated by measurement of the dynamic striatal binding of 11C-raclopride, a well-documented D2 dopaminergic receptor ligand, in rat brain after intravenous injection of the labeled compound. The effects of preinjection of the unlabeled ligand (raclopride, 2 mg/kg intravenously) and of increasing the synaptic dopamine level (amphetamine treatment, 1 mg/kg intravenously) or of depleting synaptic dopamine (reserpine pretreatment, 5 mg/kg intraperitoneally) on in vivo 11C-raclopride binding were monitored by SIC. Results: The radioactivity curves measured as a function of time were reproducible and consistent with previous studies using PET imaging (ratio of striatum to cerebellum, 2.6 ± 0.3 after 20 min). Further studies showed significant displacement of 11C-raclopride by its stable analog. Finally, the device proved its capacity to accurately detect changes in 11C-raclopride binding after a sudden (amphetamine) or a gradual (reserpine) modulation of endogenous dopamine levels. Conclusion: These results show that the new device can monitor binding of PET ligands in anesthetized rodents in vivo, with high temporal resolution.
Key Words: ß+-rangesensitive probe PET dopamine D2 receptor rat 11C-raclopride competitive binding
This article has been cited by other articles:
![]() |
A. Desbree, M. Verdurand, J. Godart, A. Dubois, R. Mastrippolito, F. Pain, L. Pinot, T. Delzescaux, H. Gurden, L. Zimmer, et al. The Potential of a Radiosensitive Intracerebral Probe to Monitor 18F-MPPF Binding in Mouse Hippocampus In Vivo J. Nucl. Med., July 1, 2008; 49(7): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pain, P. Laniece, R. Mastrippolito, P. Gervais, P. Hantraye, and L. Besret Arterial Input Function Measurement Without Blood Sampling Using a {beta}-Microprobe in Rats J. Nucl. Med., September 1, 2004; 45(9): 1577 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zimmer, L. Rbah, F. Giacomelli, D. Le Bars, and B. Renaud A Reduced Extracellular Serotonin Level Increases the 5-HT1A PET Ligand 18F-MPPF Binding in the Rat Hippocampus J. Nucl. Med., September 1, 2003; 44(9): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pain, L. Besret, F. Vaufrey, M.-C. Gregoire, L. Pinot, P. Gervais, L. Ploux, G. Bloch, R. Mastrippolito, P. Laniece, et al. In vivo quantification of localized neuronal activation and inhibition in the rat brain using a dedicated high temporal-resolution beta +-sensitive microprobe PNAS, August 6, 2002; 99(16): 10807 - 10812. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |